Plain-English translation of NCT06571487 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why some women develop high blood sugar during pregnancy (called gestational diabetes) and others don't. This study will compare how the insulin-making cells in the pancreas respond to growth hormone in two groups of women: those who had gestational diabetes and those who didn't. By learning more about these differences, scientists hope to better predict who is at risk and develop better ways to prevent or treat the condition.
Women who develop high blood sugar during pregnancy are at higher risk of developing type 2 diabetes later in life. Understanding how growth hormone affects the cells that control blood sugar could help doctors identify which women need extra monitoring or earlier treatment to stay healthy.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will visit the University of Missouri research center to have your blood drawn and tested. The study compares women with a history of gestational diabetes to a control group of women without this history, allowing researchers to see how their bodies handle growth hormone differently. The exact number and timing of visits will be explained during screening, but the study is designed to be straightforward and manageable for busy mothers.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States
Sponsor
University of Missouri-Columbia
Enrollment target
~30 participants
Started
October 2025
Primary completion
September 2028
Age range
18 Years – 45 Years
Sex
Female only
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amanda Heider
University of Missouri-Columbia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.